促进喘的预防和向喘缓解:EUFOREA关于提高喘护理标准的共识声明

相关实验视频

Updated: Jun 5, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Milos Jesenak¹, Anna Bobcakova¹, Ratko Djukanovic²

¹Department of Pediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia; Department of Pulmonology and Phthisiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia; Institute of Clinical Immunology and Medical Genetics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia.

|December 13, 2024

概括

个性化喘管理对于无法控制的严重喘至关重要. 转向以表型和内型为目标的方法可以改善结果和生活质量.

科学领域:

呼吸系统医学呼吸系统医学
过敏和免疫学过敏和免疫学
临床药理学临床药理学

背景情况:

喘显著影响生活质量,尽管在理解表型和内型方面取得了进展.
很大一部分患者患有无法控制的严重喘,有恶化的风险,需要全身皮质类固醇.
目前的指导方针建议对不受控制的严重喘进行个性化管理.

研究的目的:

总结目前的概念和专家建议,以优化喘护理.
倡导早期实施个性化喘管理策略.
为了防止系统性皮质类固醇的过度使用,并减轻严重喘患者的疾病进展.

主要方法:

召集欧洲过敏和呼吸道疾病研究和教育论坛 (EUFOREA) 专家小组.
讨论和达成共识,以解决失控严重喘的策略.
审查当前对喘表型和内型的理解.

主要成果:

一种共识观点,倡导一种整体的,个性化的喘管理方法.
在疾病管理中早期实施表型和内型向策略的理由.
确定未来临床试验和人口研究的未满足需求.

结论:

从症状驱动转向个性化,有针对性的喘管理至关重要.
早期,个性化的治疗可以制疾病的进程,并改善临床结果.
建议采用整体方法,以保持喘患者与健康有关的生活质量.

关键词:

过敏原免疫疗法免疫疗法喘管理喘管理生物学的生物学.生物标志物生物标志物这种疾病是共患的.疾病的修改疾病的修改预防预防预防缓解缓解是一种缓解.

更多相关视频

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

相关概念视频

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-IV: Nursing Management

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...

Asthma-III: Symptoms and Complications

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...